Dr. Strom studies various types of breast cancer, particularly rare forms that are often challenging to diagnose and treat. She has researched cases like angiosarcoma and adenoid cystic carcinoma, which present unique treatment difficulties, and has emphasized the importance of customized treatment approaches. Additionally, she explores the effects of surgical stress on heart conditions and assesses the risks associated with injuries in elderly patients, providing critical insights that can lead to better management and outcomes for these vulnerable populations.
Key findings
In a case of secondary breast angiosarcoma, timely surgical intervention was crucial for a woman diagnosed five years after receiving radiation therapy for ductal carcinoma in situ.
A 64-year-old woman with recurrent adenoid cystic carcinoma demonstrated the need for more aggressive treatment plans, as her cancer recurred three years after initial treatment despite multiple therapies.
Research on a 62-year-old woman revealed that surgical stress could trigger spontaneous coronary artery dissection, a serious heart condition, even in individuals without typical risk factors.
A significant study on a 65-year-old woman showed that a breast hematoma could lead to life-threatening hemorrhagic shock, underscoring the necessity for immediate and comprehensive care in elderly trauma patients.
The finding of a non-cancerous intraosseous hemangioma in a 44-year-old woman prevented unnecessary surgical interventions after confirming its benign nature.
Frequently asked questions
Does Dr. Strom study breast cancer?
Yes, Dr. Strom specializes in various types of breast cancer, focusing on rare forms and their treatment options.
What specific treatments has Dr. Strom researched?
She has researched a range of treatments for rare breast cancers, including chemotherapy and surgery, often emphasizing the need for individualized treatment approaches.
How does Dr. Strom's work impact elderly patients?
Her research examines the risks and management of breast injuries and surgical outcomes in elderly patients, providing vital insights to enhance their care.
What can patients learn from Dr. Strom's findings on heart conditions?
Her studies highlight the potential risks of spontaneous coronary artery dissection triggered by surgical stress, which is important for patients undergoing significant operations.
Are her studies relevant for young cancer patients?
Yes, her research includes important findings for young patients, especially those with genetic conditions that increase cancer risk, underlining the importance of tailored monitoring and treatment.
Publications in plain English
Can a breast hematoma lead to hemorrhagic shock in elderly trauma patients with multiple comorbidities and reduced physiological reserve? Examining the risks and management strategies.
2025
Radiology case reports
Okunlola O, Louis M, Grabill N, Strom P, Gibson B
Plain English This study focused on a 65-year-old woman who suffered a serious breast injury after a car accident. Despite appearing stable initially, she quickly faced life-threatening issues due to a large blood collection in her breast, which caused low blood pressure and confusion. Immediate treatments like blood transfusions and breathing support were crucial for her recovery, highlighting that elderly patients with existing health problems can rapidly develop severe complications from such injuries.
Who this helps: This research benefits doctors and healthcare providers caring for elderly patients with multiple health issues.
Surgical stress as a potential trigger for spontaneous coronary artery dissection: A case report.
2025
International journal of surgery case reports
Rivera A, Plumber N, Louis M, Grabill N, Strom P
Plain English This paper studied a rare heart condition called spontaneous coronary artery dissection (SCAD) in a 62-year-old woman who developed chest pain after major surgery. It was found that surgical stress may trigger SCAD, even in patients without traditional risk factors like smoking or high cholesterol. In this case, the woman showed signs of heart problems shortly after her surgery, and doctors were able to identify and treat the SCAD, which can improve outcomes for similar patients.
Who this helps: This helps patients who undergo major surgeries and may be at risk for heart complications.
A rare case of recurrent adenoid cystic carcinoma of the breast with weak hormone receptor positivity.
2025
Radiology case reports
Ray JW, Louis M, Grabill N, Ruiz JM, Strom P
Plain English This study looks at a very rare type of breast cancer called adenoid cystic carcinoma (ACC), which makes up less than 0.1% of all breast cancers. The researchers describe the case of a 64-year-old woman who had multiple treatments, including chemotherapy and surgery, but still faced a recurrent tumor three years later. The findings highlight the difficulty in treating this cancer and suggest that more aggressive surgery could lead to better outcomes, emphasizing the need for customized treatment plans for patients.
Who this helps: This helps patients with rare breast cancers and doctors treating them.
Secondary Breast Angiosarcoma Five Years After Radiation Therapy for Ductal Carcinoma In Situ.
2025
Cureus
Wyer A, Louis M, Grabill N, Brown P, Strom P
Plain English This study looked at a 56-year-old woman who developed a rare and aggressive breast cancer called angiosarcoma five years after she received radiation therapy for an earlier breast condition called ductal carcinoma in situ. The woman's symptoms included skin changes on her breast, which were ultimately diagnosed as angiosarcoma after imaging and biopsies. Timely and thorough treatment, including surgery to remove the tumor with a wide margin, was necessary because of the cancer's aggressive nature.
Who this helps: This information benefits breast cancer survivors and healthcare providers who manage their long-term care.
Her2-positive breast cancer in a young patient with Li-Fraumeni syndrome: A comprehensive case study.
2024
International journal of surgery case reports
Louis M, Fang J, Grabill N, Singh H, Strom P
Plain English This study examined a 21-year-old woman with a rare genetic condition called Li-Fraumeni syndrome, which greatly increases her risk for different cancers, including breast cancer. She had an aggressive form of breast cancer known as Her2-positive, but after receiving a specific combination of chemotherapy, her cancer completely responded to treatment. The findings underline the importance of early genetic testing and tailored management strategies for young patients with this condition, as they face unique challenges in both treatment and ongoing health monitoring.
Who this helps: This benefits young cancer patients with genetic conditions and their healthcare providers.
Leading Through Noise: Operating Room Noise Challenges for Staff and Leadership Techniques to Ensure Optimal Operational Performance.
2024
Cureus
Louis M, Grabill N, Strom P, Gibson B
Plain English This paper looks at how noise in operating rooms (ORs) affects surgeries and patient care, especially during trauma procedures where distractions can lead to mistakes. It found that sounds from equipment and staff conversations often exceed recommended noise levels, contributing to higher cognitive loads and error rates. The study emphasizes the importance of reducing noise through better OR design, communication protocols, and leadership strategies to improve surgical efficiency and safety.
Who this helps: This research benefits patients and surgical teams by promoting safer and more effective operating environments.
Dormancy Leading to Late Recurrence in Breast Cancer: A Case of Hormone Receptor-Positive Supraclavicular Metastasis 10 Years After the Initial Treatment.
2024
Cureus
Louis M, Tapia R, Grabill N, Strom P
Plain English This study looked at how breast cancer can come back many years after treatment, especially in cases that are hormone receptor-positive (HR+). Researchers found that even after 10 years of being cancer-free, a 65-year-old woman developed a recurrence in her lymph nodes, indicating that dormant cancer cells can reactivate long after the initial treatment. This is important because it highlights the need for long-term monitoring and tailored treatment plans to effectively manage the risk of late recurrence.
Who this helps: This helps patients with hormone receptor-positive breast cancer, as well as their doctors in creating more effective follow-up strategies.
Intraosseous Hemangioma of the Iliac Bone: An Incidental Finding Mimicking Metastatic Disease.
2024
Cureus
Louis M, Hayden A, Grabill N, Strom P
Plain English Researchers studied a rare type of benign tumor called an intraosseous hemangioma found in the iliac bone of a 44-year-old woman who was undergoing tests for kidney stones. Initially, doctors worried that the 1.2 cm lesion might be cancer, but after several tests, they confirmed it was a non-cancerous growth, which avoids the need for surgery and reduces potential risks. This finding is important because accurately diagnosing this condition can prevent unnecessary treatments and improve patient care.
Who this helps: This benefits patients who may undergo similar imaging tests and doctors making diagnoses.
Axillary chest wall solid-papillary carcinoma: A case report on presentation and management.
2023
Rare tumors
Niver HE, Strom P
Plain English This study looked at a rare type of breast cancer called solid-papillary carcinoma, which usually affects older women and is found in less than 1% of all breast cancers. The researchers reported a case where this cancer appeared on the chest wall after a mastectomy, highlighting that it can be more serious than previously thought. They aim to raise awareness about its aggressive nature to help avoid misdiagnosis and unnecessary treatments.
Who this helps: This helps patients, especially elderly women who may have this type of breast cancer.
Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
2018
Journal of the National Cancer Institute
Wallerstedt A, Strom P, Gronberg H, Nordstrom T, Eklund M
Plain English This study looked at how a medication called 5α-reductase inhibitors (5-ARIs), which is used for urinary issues, affects the risk of prostate cancer in men. Out of more than 333,000 men studied, those who took 5-ARIs had a reduced overall risk of developing prostate cancer. Specifically, men who used the medication for more than four years saw their risk drop significantly, with a 69% lower risk for those using it for six to eight years compared to those who didn't use it.
Who this helps: This information benefits men with urinary symptoms, doctors treating them, and those concerned about prostate cancer.
Mena Louis Nathaniel Grabill Brian Gibson Abigayle Wyer Pierpont Brown Jonathan W Ray Jaime Morel Ruiz Angelica Rivera Noorine Plumber Oluwasemilore Okunlola
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.